ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
This site is part of the Siconnects Division of Sciinov Group
This site is operated by a business or businesses owned by Sciinov Group and all copyright resides with them.
ADD THESE DATES TO YOUR E-DIARY OR GOOGLE CALENDAR
Auckland University of Technology, New Zealand
Title:Artificial Intelligence in Dementia Care: Revolutionizing Diagnosis, Drug Discovery, and Personalized Medicine
Artificial Intelligence (AI) and Machine Learning (ML) are redefining dementia care, from diagnosis to drug discovery, with unprecedented precision and scalability. This work explores AIdriven methodologies for analyzing multimodal datasets—spanning neuroimaging, genetic biomarkers, clinical parameters, and demographic profiles—enhancing early detection and tracking of Alzheimer's Disease (AD), Frontotemporal, Lewy Body, and Vascular Dementias. Advanced algorithms, including Vision Transformers, Graph Neural Networks, and Spiking Neural Networks, offer actionable insights by revealing intricate disease patterns and tailoring precision medicine strategies to individual needs. This research also emphasizes the challenges of AI integration in clinical practice, including model interpretability, data privacy, and validation. Additionally, it highlights ethical considerations and the need for equitable AI frameworks to ensure global accessibility. By leveraging cutting-edge AI techniques, this study not only accelerates therapeutic advancements but also establishes a robust foundation for future dementia research and patient care. These efforts signify a paradigm shift in healthcare, transforming dementia management and enabling improved quality of life for millions globally.
Dr. Helena Bahrami is an expert in brain-inspired AI, specializing in Spiking Neural Networks and quantum-inspired deep learning. Her ground-breaking work at Auckland University of Technology enhances neurodegenerative disease diagnosis and drug discovery. Helena collaborates globally, applying AI to targeted cancer therapies using genetic data. As an industrial leader, she develops innovative AI applications, bridging healthcare and technology. Passionate about equity, she integrates AI and 3D visualization to create accessible health solutions. Helena’s transformative contributions empower individuals and redefine healthcare’s future through cutting-edge research and industry collaboration.